New England Journal of Medicine
The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on a wide variety of topics.
The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on biomedical science and clinical practice.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Feb 10, 2021 · Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle ...
Toxic Effects from Ivermectin Use Associated with Prevention and ...
Oct 20, 2021 · The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the d...
Coronavirus (Covid-19) | NEJM
Jul 17, 2024 · Explore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Dec 10, 2020 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe ...
Tirzepatide versus Semaglutide Once Weekly in Patients with Type …
Jun 25, 2021 · Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes. The efficacy ...
Dapagliflozin in Patients with Chronic Kidney Disease - The New …
Sep 24, 2020 · Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diab...
Biologic Therapies for Severe Asthma - The New England Journal …
Jan 12, 2022 · Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden. This...
Current Issue - The New England Journal of Medicine
Explore the current issue of The New England Journal of Medicine (Vol. 392 No. 4).